UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000016507
Receipt number	R000019170
Scientific Title	A phase II study of erlotinib plus bevacizumab in patients with performance status 2 to 3 and EGFR mutation-positive advanced non-small-cell lung cancer
Date of disclosure of the study information	2015/02/10
Last modified on	2016/02/10 18:33:56

---